tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Joseph Thome, 23 are a BUY (63.89%), 13 are a HOLD (36.11%).
Analyst Joseph Thome, currently employed at TD COWEN, carries an average stock price target met ratio of 54.32% that have a potential upside of 33.16% achieved within 165 days. Previously, Joseph Thome worked at COWEN.
Joseph Thome’s has documented 73 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PTCT, PTC Therapeutics at 07-May-2025.
Analyst best performing recommendations are on PTCT (PTC THERAPEUTICS).
The best stock recommendation documented was for PTCT (PTC THERAPEUTICS) at 7/20/2020. The price target of $50 was fulfilled within 1 day with a profit of $3.29 (6.17%) receiving and performance score of 61.74.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Apr-2019
$205
$20.75 (11.26%)
$85
8 days ago
(28-Jan-2026)
7/8 (87.5%)
$16.98 (9.03%)
433
Buy Since 07-Jun-2018
$260
$75.75 (41.11%)
$200
15 days ago
(21-Jan-2026)
22/45 (48.89%)
$75.5 (40.92%)
515
Buy Since 08-Aug-2023
$223
$38.75 (21.03%)
$113
20 days ago
(16-Jan-2026)
3/4 (75%)
$48.86 (28.06%)
189
Buy Since 29-Apr-2024
$204
$19.75 (10.72%)
$190
28 days ago
(08-Jan-2026)
19/21 (90.48%)
$33.31 (19.51%)
356
Buy Since 06-Feb-2024
$248
$63.75 (34.60%)
$105
30 days ago
(06-Jan-2026)
4/5 (80%)
$76.51 (44.61%)
261
What Year was the first public recommendation made by Joseph Thome?
